
CRWD · Nasdaq
Consensus is Buy across 44 analysts. The supplied consensus reports a $240 mean target, but lists both the low and high at $520, so the target range and its spread cannot be interpreted reliably. Among named analysts, Mizuho is the most bullish with a reported $520 target, while Wedbush is less bullish at $250; the least bullish named analyst cannot be identified from the evidence. The only clearly stated recent action is Wedbush assuming Outperform with a $250 target, and no prior target is supplied, so the direction of revisions over the past week cannot be established. The substantive disagreement is whether AI-led cybersecurity demand and CrowdStrike’s competitive position justify a premium valuation despite FY2026 net losses; the target data itself is inconsistent.
| Firm | Analyst | Rating | Price Target | Upside | Date | Source |
|---|---|---|---|---|---|---|
| Mizuho | — | $520 | +120.9% | Apr 27, 2026 | Open the report this row came from | |
| Mizuho | — | $520 | +120.9% | Apr 27, 2026 |